Invention Grant
![2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof](/docs/US/2023-06-06/US11667632B2/abs.jpg.600x600.jpg)
- Patent Title: 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof
-
Application No.: US17112282Application Date: 2020-12-04
-
Publication No.: US11667632B2Publication Date: 2023-06-06
- Inventor: John Hood , David Mark Wallace , Sunil Kumar KC , Yusuf Yazici , Christopher Swearingen , Luis A Dellamary
- Applicant: BioSplice Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: BioSplice Therapeutics, Inc.
- Current Assignee: BioSplice Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/444
- IPC: A61K31/444 ; A61P19/02 ; A61P29/00 ; C07D471/04 ; A61K31/4545 ; A61K31/496 ; A61K31/5377 ; A61K9/00
![2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof](/abs-image/US/2023/06/06/US11667632B2/abs.jpg.150x150.jpg)
Abstract:
Indazole compounds for treating various diseases and pathologies are provided. More particularly, the use of an indazole compound or analogs thereof, in the treatment of inflammatory diseases or disorders is provided.
Public/Granted literature
- US20210292319A1 2-(1H-INDAZOL-3-YL)-3H-IMIDAZO[4,5-C]PYRIDINES AND THEIR ANTI-INFLAMMATORY USES THEREOF Public/Granted day:2021-09-23
Information query
IPC分类:
